Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2012-09-06 21:03:19 UTC
Update Date2021-09-14 15:37:03 UTC
HMDB IDHMDB0029004
Secondary Accession Numbers
  • HMDB29004
Metabolite Identification
Common NamePhenylalanylserine
DescriptionPhenylalanylserine is a dipeptide composed of phenylalanine and serine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Structure
Data?1582753365
Synonyms
ValueSource
FSChEBI
L-Phe-L-serChEBI
F-S DipeptideHMDB
FS DipeptideHMDB
L-Phenylalanyl-L-serineHMDB
N-L-Phenylalanyl-L-serineHMDB
N-PhenylalanylserineHMDB
Phe-serHMDB
Phenylalanine serine dipeptideHMDB
Phenylalanine-serine dipeptideHMDB
Phenylalanyl-serineHMDB
PhenylalanylserineHMDB, ChEBI
Chemical FormulaC12H16N2O4
Average Molecular Weight252.27
Monoisotopic Molecular Weight252.111007003
IUPAC Name(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-hydroxypropanoic acid
Traditional Name(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-hydroxypropanoic acid
CAS Registry Number16053-39-7
SMILES
N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O
InChI Identifier
InChI=1S/C12H16N2O4/c13-9(6-8-4-2-1-3-5-8)11(16)14-10(7-15)12(17)18/h1-5,9-10,15H,6-7,13H2,(H,14,16)(H,17,18)/t9-,10-/m0/s1
InChI KeyROHDXJUFQVRDAV-UWVGGRQHSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentDipeptides
Alternative Parents
Substituents
  • Alpha-dipeptide
  • Phenylalanine or derivatives
  • N-acyl-alpha-amino acid
  • N-acyl-alpha amino acid or derivatives
  • N-acyl-l-alpha-amino acid
  • Alpha-amino acid amide
  • Serine or derivatives
  • Alpha-amino acid or derivatives
  • Amphetamine or derivatives
  • Beta-hydroxy acid
  • Aralkylamine
  • Hydroxy acid
  • Fatty amide
  • Monocyclic benzene moiety
  • Benzenoid
  • Fatty acyl
  • Carboxamide group
  • Amino acid or derivatives
  • Secondary carboxylic acid amide
  • Amino acid
  • Carboxylic acid
  • Monocarboxylic acid or derivatives
  • Alcohol
  • Primary aliphatic amine
  • Organonitrogen compound
  • Organooxygen compound
  • Primary alcohol
  • Carbonyl group
  • Primary amine
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Amine
  • Organic oxygen compound
  • Organic nitrogen compound
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogP-2.77Extrapolated
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility3.89 g/LALOGPS
logP-2.1ALOGPS
logP-2.8ChemAxon
logS-1.8ALOGPS
pKa (Strongest Acidic)3.55ChemAxon
pKa (Strongest Basic)8.01ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area112.65 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity63.96 m³·mol⁻¹ChemAxon
Polarizability25.25 ųChemAxon
Number of Rings1ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+159.32330932474
DeepCCS[M-H]-156.92730932474
DeepCCS[M-2H]-189.94130932474
DeepCCS[M+Na]+165.37430932474

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022.1.98 minutes32390414
Predicted by Siyang on May 30, 202210.188 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20228.39 minutes32390414
AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid303.9 seconds40023050
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid735.9 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid235.9 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid83.0 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid171.8 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid84.0 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid272.5 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid297.2 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)779.9 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid663.9 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid202.6 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid817.5 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid178.2 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid223.6 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate429.5 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA410.0 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water184.4 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
PhenylalanylserineN[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O3571.5Standard polar33892256
PhenylalanylserineN[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O2103.1Standard non polar33892256
PhenylalanylserineN[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O2447.0Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Phenylalanylserine,1TMS,isomer #1C[Si](C)(C)OC[C@H](NC(=O)[C@@H](N)CC1=CC=CC=C1)C(=O)O2314.5Semi standard non polar33892256
Phenylalanylserine,1TMS,isomer #2C[Si](C)(C)OC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=CC=C12265.8Semi standard non polar33892256
Phenylalanylserine,1TMS,isomer #3C[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)O2314.5Semi standard non polar33892256
Phenylalanylserine,1TMS,isomer #4C[Si](C)(C)N(C(=O)[C@@H](N)CC1=CC=CC=C1)[C@@H](CO)C(=O)O2235.2Semi standard non polar33892256
Phenylalanylserine,2TMS,isomer #1C[Si](C)(C)OC[C@H](NC(=O)[C@@H](N)CC1=CC=CC=C1)C(=O)O[Si](C)(C)C2242.1Semi standard non polar33892256
Phenylalanylserine,2TMS,isomer #2C[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO[Si](C)(C)C)C(=O)O2315.7Semi standard non polar33892256
Phenylalanylserine,2TMS,isomer #3C[Si](C)(C)OC[C@@H](C(=O)O)N(C(=O)[C@@H](N)CC1=CC=CC=C1)[Si](C)(C)C2258.8Semi standard non polar33892256
Phenylalanylserine,2TMS,isomer #4C[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)O[Si](C)(C)C2281.3Semi standard non polar33892256
Phenylalanylserine,2TMS,isomer #5C[Si](C)(C)OC(=O)[C@H](CO)N(C(=O)[C@@H](N)CC1=CC=CC=C1)[Si](C)(C)C2193.4Semi standard non polar33892256
Phenylalanylserine,2TMS,isomer #6C[Si](C)(C)N([C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)O)[Si](C)(C)C2465.1Semi standard non polar33892256
Phenylalanylserine,2TMS,isomer #7C[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N([C@@H](CO)C(=O)O)[Si](C)(C)C2284.4Semi standard non polar33892256
Phenylalanylserine,3TMS,isomer #1C[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO[Si](C)(C)C)C(=O)O[Si](C)(C)C2287.1Semi standard non polar33892256
Phenylalanylserine,3TMS,isomer #1C[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO[Si](C)(C)C)C(=O)O[Si](C)(C)C2332.2Standard non polar33892256
Phenylalanylserine,3TMS,isomer #2C[Si](C)(C)OC[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H](N)CC1=CC=CC=C1)[Si](C)(C)C2226.1Semi standard non polar33892256
Phenylalanylserine,3TMS,isomer #2C[Si](C)(C)OC[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H](N)CC1=CC=CC=C1)[Si](C)(C)C2289.8Standard non polar33892256
Phenylalanylserine,3TMS,isomer #3C[Si](C)(C)OC[C@H](NC(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O2450.2Semi standard non polar33892256
Phenylalanylserine,3TMS,isomer #3C[Si](C)(C)OC[C@H](NC(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O2409.6Standard non polar33892256
Phenylalanylserine,3TMS,isomer #4C[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N([C@@H](CO[Si](C)(C)C)C(=O)O)[Si](C)(C)C2298.6Semi standard non polar33892256
Phenylalanylserine,3TMS,isomer #4C[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N([C@@H](CO[Si](C)(C)C)C(=O)O)[Si](C)(C)C2378.1Standard non polar33892256
Phenylalanylserine,3TMS,isomer #5C[Si](C)(C)OC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C2427.2Semi standard non polar33892256
Phenylalanylserine,3TMS,isomer #5C[Si](C)(C)OC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C2376.7Standard non polar33892256
Phenylalanylserine,3TMS,isomer #6C[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N([C@@H](CO)C(=O)O[Si](C)(C)C)[Si](C)(C)C2245.5Semi standard non polar33892256
Phenylalanylserine,3TMS,isomer #6C[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N([C@@H](CO)C(=O)O[Si](C)(C)C)[Si](C)(C)C2335.0Standard non polar33892256
Phenylalanylserine,3TMS,isomer #7C[Si](C)(C)N(C(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C)[C@@H](CO)C(=O)O2379.9Semi standard non polar33892256
Phenylalanylserine,3TMS,isomer #7C[Si](C)(C)N(C(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C)[C@@H](CO)C(=O)O2426.0Standard non polar33892256
Phenylalanylserine,4TMS,isomer #1C[Si](C)(C)OC[C@H](NC(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C2414.0Semi standard non polar33892256
Phenylalanylserine,4TMS,isomer #1C[Si](C)(C)OC[C@H](NC(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C2450.6Standard non polar33892256
Phenylalanylserine,4TMS,isomer #2C[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N([C@@H](CO[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C2280.5Semi standard non polar33892256
Phenylalanylserine,4TMS,isomer #2C[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N([C@@H](CO[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C2396.8Standard non polar33892256
Phenylalanylserine,4TMS,isomer #3C[Si](C)(C)OC[C@@H](C(=O)O)N(C(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C2440.9Semi standard non polar33892256
Phenylalanylserine,4TMS,isomer #3C[Si](C)(C)OC[C@@H](C(=O)O)N(C(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C2495.7Standard non polar33892256
Phenylalanylserine,4TMS,isomer #4C[Si](C)(C)OC(=O)[C@H](CO)N(C(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C2407.6Semi standard non polar33892256
Phenylalanylserine,4TMS,isomer #4C[Si](C)(C)OC(=O)[C@H](CO)N(C(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C2463.1Standard non polar33892256
Phenylalanylserine,5TMS,isomer #1C[Si](C)(C)OC[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C2496.9Semi standard non polar33892256
Phenylalanylserine,5TMS,isomer #1C[Si](C)(C)OC[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C2519.0Standard non polar33892256
Phenylalanylserine,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC[C@H](NC(=O)[C@@H](N)CC1=CC=CC=C1)C(=O)O2557.2Semi standard non polar33892256
Phenylalanylserine,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=CC=C12530.6Semi standard non polar33892256
Phenylalanylserine,1TBDMS,isomer #3CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)O2540.8Semi standard non polar33892256
Phenylalanylserine,1TBDMS,isomer #4CC(C)(C)[Si](C)(C)N(C(=O)[C@@H](N)CC1=CC=CC=C1)[C@@H](CO)C(=O)O2506.5Semi standard non polar33892256
Phenylalanylserine,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC[C@H](NC(=O)[C@@H](N)CC1=CC=CC=C1)C(=O)O[Si](C)(C)C(C)(C)C2727.2Semi standard non polar33892256
Phenylalanylserine,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO[Si](C)(C)C(C)(C)C)C(=O)O2763.7Semi standard non polar33892256
Phenylalanylserine,2TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC[C@@H](C(=O)O)N(C(=O)[C@@H](N)CC1=CC=CC=C1)[Si](C)(C)C(C)(C)C2760.1Semi standard non polar33892256
Phenylalanylserine,2TBDMS,isomer #4CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)O[Si](C)(C)C(C)(C)C2746.9Semi standard non polar33892256
Phenylalanylserine,2TBDMS,isomer #5CC(C)(C)[Si](C)(C)OC(=O)[C@H](CO)N(C(=O)[C@@H](N)CC1=CC=CC=C1)[Si](C)(C)C(C)(C)C2729.6Semi standard non polar33892256
Phenylalanylserine,2TBDMS,isomer #6CC(C)(C)[Si](C)(C)N([C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)O)[Si](C)(C)C(C)(C)C2908.4Semi standard non polar33892256
Phenylalanylserine,2TBDMS,isomer #7CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N([C@@H](CO)C(=O)O)[Si](C)(C)C(C)(C)C2755.3Semi standard non polar33892256
Phenylalanylserine,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C2947.9Semi standard non polar33892256
Phenylalanylserine,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C2898.8Standard non polar33892256
Phenylalanylserine,3TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H](N)CC1=CC=CC=C1)[Si](C)(C)C(C)(C)C2959.5Semi standard non polar33892256
Phenylalanylserine,3TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H](N)CC1=CC=CC=C1)[Si](C)(C)C(C)(C)C2860.0Standard non polar33892256
Phenylalanylserine,3TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC[C@H](NC(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O3133.3Semi standard non polar33892256
Phenylalanylserine,3TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC[C@H](NC(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O2942.1Standard non polar33892256
Phenylalanylserine,3TBDMS,isomer #4CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N([C@@H](CO[Si](C)(C)C(C)(C)C)C(=O)O)[Si](C)(C)C(C)(C)C2982.5Semi standard non polar33892256
Phenylalanylserine,3TBDMS,isomer #4CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N([C@@H](CO[Si](C)(C)C(C)(C)C)C(=O)O)[Si](C)(C)C(C)(C)C2919.4Standard non polar33892256
Phenylalanylserine,3TBDMS,isomer #5CC(C)(C)[Si](C)(C)OC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3120.9Semi standard non polar33892256
Phenylalanylserine,3TBDMS,isomer #5CC(C)(C)[Si](C)(C)OC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2925.2Standard non polar33892256
Phenylalanylserine,3TBDMS,isomer #6CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N([C@@H](CO)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2943.1Semi standard non polar33892256
Phenylalanylserine,3TBDMS,isomer #6CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N([C@@H](CO)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2898.9Standard non polar33892256
Phenylalanylserine,3TBDMS,isomer #7CC(C)(C)[Si](C)(C)N(C(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[C@@H](CO)C(=O)O3097.9Semi standard non polar33892256
Phenylalanylserine,3TBDMS,isomer #7CC(C)(C)[Si](C)(C)N(C(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[C@@H](CO)C(=O)O2952.6Standard non polar33892256
Phenylalanylserine,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC[C@H](NC(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C3331.5Semi standard non polar33892256
Phenylalanylserine,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC[C@H](NC(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C3127.9Standard non polar33892256
Phenylalanylserine,4TBDMS,isomer #2CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N([C@@H](CO[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3166.9Semi standard non polar33892256
Phenylalanylserine,4TBDMS,isomer #2CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N([C@@H](CO[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3087.7Standard non polar33892256
Phenylalanylserine,4TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC[C@@H](C(=O)O)N(C(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3336.6Semi standard non polar33892256
Phenylalanylserine,4TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC[C@@H](C(=O)O)N(C(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3166.7Standard non polar33892256
Phenylalanylserine,4TBDMS,isomer #4CC(C)(C)[Si](C)(C)OC(=O)[C@H](CO)N(C(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3281.6Semi standard non polar33892256
Phenylalanylserine,4TBDMS,isomer #4CC(C)(C)[Si](C)(C)OC(=O)[C@H](CO)N(C(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3164.4Standard non polar33892256
Phenylalanylserine,5TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3525.0Semi standard non polar33892256
Phenylalanylserine,5TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3328.5Standard non polar33892256
Spectra
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Feces
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Normal
details
Abnormal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)BothColorectal Cancer details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Colorectal cancer
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Colorectal cancer
details
Associated Disorders and Diseases
Disease References
Colorectal cancer
  1. Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
  2. Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
  3. Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
Associated OMIM IDs
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDFDB112020
KNApSAcK IDNot Available
Chemspider ID167923
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound193508
PDB IDNot Available
ChEBI ID71032
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Mizuma T, Narasaka T, Awazu S: Uptake of cyclic dipeptide by PEPT1 in Caco-2 cells: phenolic hydroxyl group of substrate enhances affinity for PEPT1. J Pharm Pharmacol. 2002 Sep;54(9):1293-6. [PubMed:12356285 ]
  2. Mizuma T, Narasaka T, Awazu S: Concentration-dependent atypical intestinal absorption of cyclic phenylalanylserine: small intestine acts as an interface between the body and ingested compounds. Biol Pharm Bull. 2003 Nov;26(11):1625-8. [PubMed:14600416 ]
  3. Schwarz A, Steinke D, Kula MR, Wandrey C: Optimization of enzyme-mediated peptide bond formation. Biotechnol Appl Biochem. 1990 Apr;12(2):188-95. [PubMed:2109983 ]
  4. Behling RA, Fischer AG: Formation of phenylalanylserine and cyclo-phenylalanylseryl by protoplasts of Gliocladium virens. Int J Biochem. 1980;11(5):457-8. [PubMed:6156101 ]
  5. Bucevic-Popovic V, Pavela-Vrancic M, Dieckmann R, Von Dohren H: Relationship between activating and editing functions of the adenylation domain of apo-tyrocidin synthetase 1 (apo-TY1). Biochimie. 2006 Mar-Apr;88(3-4):265-70. Epub 2005 Sep 15. [PubMed:16182433 ]
  6. Mizuma T, Narasaka T, Hiyoshi W, Awazu S: Concentration-dependent preferences of absorptive and excretive transport cause atypical intestinal absorption of cyclic phenylalanylserine: small intestine acts as an interface between the body and ingested compounds. Res Commun Mol Pathol Pharmacol. 2002;111(5-6):199-209. [PubMed:15244036 ]